Back to search
FDAFDA · Food and drugs·Recall number D-0074-2022

North by Honeywell PAIN STOPPER EXTRA STRENGTH (Acetaminophen 250 mg, Aspirin 250 mg, Caffeine 65 mg) tablets, 2 tablets per packet, Packaged in 5,000 Packets/Case, PO# B121242, Item# 853500-01, Dist. By Honeywell Safety Products USA, Smithfield, RI 02917

Published November 3, 2021 · Recall initiated: October 13, 2021

Summary

FDA records drug Class III recall D-0074-2022, published November 3, 2021 and initiated October 13, 2021. Recalling firm: Ultra Seal Corporation; Status: Terminated; Reported quantity: 250,000 tablets; Lot: Lot #: AK-9371, exp. date 21-Nov. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Ultra Seal Corporation
Distributor
Nationwide in the USA.
Lot
Lot #: AK-9371, exp. date 21-Nov
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was North by Honeywell PAIN STOPPER EXTRA STRENGTH (Acetaminophen 250 mg, Aspirin 250 mg, Caffeine 65 mg) tablets, 2 tablets per packet, Packaged in 5,000 Packets/Case, PO# B121242, Item# 853500-01, Dist. By Honeywell Safety Products USA, Smithfield, RI 02917 recalled?

Yes. FDA published recall D-0074-2022 on November 3, 2021. Reported hazard: Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.

What should I do if I have this product?

Voluntary: Firm initiated · Letter